Literature DB >> 12578287

Lipoprotein(a) as a potent risk indicator for early cardiovascular disease.

A Dirisamer1, K Widhalm.   

Abstract

AIM: Elevated levels of lipoprotein (a) [Lp(a)] are associated with increased cardiovascular risk in adults. It is not known whether Lp(a) elevation can be regarded as an additional risk factor even in children and adolescents. Therefore the purpose of this study was to compare the serum concentrations, distribution and frequency of Lp(a) and lipids of children and adolescents with premature parental and/or grandparental cardiovascular disease (CVD) with controls.
METHODS: 103 children and adolescents, aged 6-18 y, from families with premature CVD in a parent and/or grandparent, i.e. before the age of 55 y, and 103 controls were estimated for lipids and Lp(a).
RESULTS: Mean levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and Lp(a) were significantly higher in the risk than in the control group. Median Lp(a) levels were 20 (10-61.5) mg dl(-1) in the risk subjects, and 15 (6-26.5) mg dl(-1) in the control subjects (p = 0.005). Mean TC and LDL-C concentrations of the risk group compared with the control group were 211 mg dl(-1) (5.5 mmoll(-1)) versus 165mg dl(-1) (4.3mmol l(-1)) (p < 0.0001), and 140 mg dl(-1) (3.6 mmol l(-1)) versus 101 mg dl(-1) (2.6 mmol l(-1)) (p < 0.0001), respectively.
CONCLUSION: It may be important to estimate plasma Lp(a) levels in progeny with a familial history of premature CVD, because it seems possible to identify those subjects who are at greater risk for later CVD either with or without elevated LDL-C levels.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12578287     DOI: 10.1080/08035250216114

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  4 in total

1.  Lipoprotein (a): Examination of Cardiovascular Risk in a Pediatric Referral Population.

Authors:  Omar Qayum; Noor Alshami; Chizitam F Ibezim; Kimberly J Reid; Janelle R Noel-MacDonnell; Geetha Raghuveer
Journal:  Pediatr Cardiol       Date:  2018-06-13       Impact factor: 1.655

2.  Correlates of serum lipoprotein (A) in children and adolescents in the United States. The third National Health Nutrition and Examination Survey (NHANES-III).

Authors:  Thomas O Obisesan; Muktar H Aliyu; Abayomi S Adediran; Vernon Bond; Celia J Maxwell; Charles N Rotimi
Journal:  Lipids Health Dis       Date:  2004-12-16       Impact factor: 3.876

3.  Frequency of secondary dyslipidemia in obese children.

Authors:  Ulrike Korsten-Reck; Katrin Kromeyer-Hauschild; Katrin Korsten; Manfred W Baumstark; Hans-H Dickhuth; Aloys Berg
Journal:  Vasc Health Risk Manag       Date:  2008

Review 4.  Lipoprotein(a) in cardiovascular diseases.

Authors:  Michele Malaguarnera; Marco Vacante; Cristina Russo; Giulia Malaguarnera; Tijana Antic; Lucia Malaguarnera; Rita Bella; Giovanni Pennisi; Fabio Galvano; Alessandro Frigiola
Journal:  Biomed Res Int       Date:  2012-12-30       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.